Molina Healthcare downgraded by Cantor Fitzgerald with a new price target
$MOH
Medical Specialities
Health Care
Cantor Fitzgerald downgraded Molina Healthcare from Overweight to Neutral and set a new price target of $210.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/24/2025 | $144.00 | Equal Weight → Underweight | Barclays |
| 10/16/2025 | $203.00 | Buy → Hold | TD Cowen |
| 10/14/2025 | $207.00 | Neutral | Goldman |
| 7/25/2025 | $210.00 | Overweight → Neutral | Cantor Fitzgerald |
| 7/25/2025 | $180.00 | Buy → Hold | Truist |
| 7/10/2025 | $266.00 | Overweight → Equal-Weight | Morgan Stanley |
| 6/9/2025 | $364.00 | Overweight | Morgan Stanley |
| 4/22/2025 | $414.00 | Outperform | Bernstein |
Barclays downgraded Molina Healthcare from Equal Weight to Underweight and set a new price target of $144.00
TD Cowen downgraded Molina Healthcare from Buy to Hold and set a new price target of $203.00
Goldman initiated coverage of Molina Healthcare with a rating of Neutral and set a new price target of $207.00
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced the closing of its previously announced offering of $850 million aggregate principal amount of 6.500% senior notes due 2031 (the "Notes") sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The Notes bear interest at a rate of 6.500% per annum. Interest on the Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing August 15, 2026 and a
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it priced $850 million aggregate principal amount of its 6.500% senior notes due 2031 (the "Notes") to be sold in a private offering to individuals reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The offering is expected to close on or about November 20, 2025 (such actual closing date, the "Settlement Date"), subject to the satisfaction of customary closing conditions. The Notes will not be guaranteed by any
Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today announced that it intends to privately offer, subject to market and other conditions, $750 million aggregate principal amount of senior notes due 2031 (the "Notes"). The Company will make the offering pursuant to an exemption under the Securities Act of 1933, as amended (the "Securities Act"). The initial purchasers will offer the Notes only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act and to certain non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act ("Regulation S"). The Notes will not be guaranteed by any of the Com
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)
4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)
Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported third quarter 2025 GAAP earnings per diluted share of $1.51 and adjusted earnings per diluted share of $1.84. Financial results are summarized below: Three months ended Nine months ended September 30, September 30, 2025 2024 2025 2024 (In millions, except per-share results) Premium Revenue $ 10,841 $ 9,694 $ 32,337
Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the third quarter ending September 30, 2025, after the market closes on Wednesday, October 22, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, October 23, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 2660919. A telephonic replay of the conference call will be available through Thursday, October 30, 2025, by dialing (877) 344-7529 and entering the confirmation number, 1905016. A live broadcast of Molina Healthcare's conference call will be available on the Company's inve
Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below: Three months ended Six months ended June 30, June 30, 2025 2024 2025 2024 (In millions, except per-share results) Premium Revenue $10,868 $9,446 $21,496 $18,950 Total Revenue $11,427
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)
SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)